Caseware UK (AP4) 2023.0.135 2023.0.135 The company operates a directors current account with the directors. The amount owed to the directors at the financial year end was £1,030 (2023: £414).false2true2023-10-01No description of principal activity2trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 09198309 2023-10-01 2024-09-30 09198309 2022-10-01 2023-09-30 09198309 2024-09-30 09198309 2023-09-30 09198309 c:Director1 2023-10-01 2024-09-30 09198309 c:Director2 2023-10-01 2024-09-30 09198309 c:RegisteredOffice 2023-10-01 2024-09-30 09198309 d:CurrentFinancialInstruments d:WithinOneYear 2024-09-30 09198309 d:CurrentFinancialInstruments d:WithinOneYear 2023-09-30 09198309 d:ShareCapital 2024-09-30 09198309 d:ShareCapital 2023-09-30 09198309 d:RetainedEarningsAccumulatedLosses 2024-09-30 09198309 d:RetainedEarningsAccumulatedLosses 2023-09-30 09198309 c:OrdinaryShareClass1 2023-10-01 2024-09-30 09198309 c:OrdinaryShareClass1 2024-09-30 09198309 c:OrdinaryShareClass1 2023-09-30 09198309 c:EntityNoLongerTradingButTradedInPast 2023-10-01 2024-09-30 09198309 c:FRS102 2023-10-01 2024-09-30 09198309 c:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 09198309 c:AbridgedAccounts 2023-10-01 2024-09-30 09198309 c:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 09198309 2 2023-10-01 2024-09-30 09198309 e:PoundSterling 2023-10-01 2024-09-30 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 09198309










OCR MEDICAL LIMITED

Unaudited
Financial statements
Information for filing with the registrar
For the year ended 30 September 2024

 
OCR MEDICAL LIMITED
 

Company Information


Directors
Dr L O'Connor-Read 
Dr R O'Connor-Read 




Registered number
09198309



Registered office
14 Endcliffe Rise Road

Sheffield

South Yorkshire

S11 8RU





 
OCR MEDICAL LIMITED
Registered number: 09198309

Balance sheet
As at 30 September 2024

2024
2023
Note
£
£

  

Current assets
  

Cash at bank and in hand
  
11,591
13,264

  
11,591
13,264

Creditors: amounts falling due within one year
  
(1,510)
(869)

Net current assets
  
 
 
10,081
 
 
12,395

Total assets less current liabilities
  
10,081
12,395

Net assets
  
10,081
12,395


Capital and reserves
  

Called up share capital 
 5 
100
100

Profit and loss account
  
9,981
12,295

  
10,081
12,395


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 10 June 2025.






Dr L O'Connor-Read
Director

The notes on pages 2 to 3 form part of these financial statements.

Page 1

 
OCR MEDICAL LIMITED
 

 
Notes to the financial statements
For the year ended 30 September 2024

1.


General information

OCR Medical Limited is a company limited by shares incorporated in England within the United Kingdom. The address of the registered office is given in the company information page of these financial statements.
The financial statements are presented in sterling which is the functional currency of the company.
The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwiase stated.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A) of the Companies Act 2006.

 
2.2

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.3

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.4

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.5

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees




The average monthly number of employees, including directors, during the year was 2 (2023 -2).

Page 2

 
OCR MEDICAL LIMITED
 

 
Notes to the financial statements
For the year ended 30 September 2024

4.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
11,591
13,264

11,591
13,264



5.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



100 (2023 -100) Ordinary shares of £1.00 each
100
100



6.


Related party transactions

The company operates a directors current account with the directors. The amount owed to the directors at the financial year end was £1,030 (2023: £414).


Page 3